Novo Nordisk now offers its comprehensive line of insulin analog products with a pregnancy Category B classification for use with the FlexPen(®), including Levemir(®) (insulin detemir [rDNA origin] injection) FlexPen(®). FlexPen(®) is a discreet, prefilled insulin pen device that gives patients the ability to manage their diabetes while they're on-the-go. FlexPen(®) is covered on more than 90 percent of insurance plans.

PRINCETON, N.J., Nov.

SAN DIEGO, April 14, 2011 /PRNewswire/ -- Halozyme Therapeutics, Inc.

ST.

PRINCETON, N.J., Jan. 13, 2011 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, has launched a comprehensive, highly customizable online support program for people living with diabetes called Cornerstones4Care(TM).